NeoGenomics, Inc. (NEO)

NeoGenomics Revenue

NeoGenomics had revenue of $610.66M in the twelve months ending March 31, 2024, with 15.27% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $156.24M with 13.86% year-over-year growth. In the year 2023, NeoGenomics had annual revenue of $591.64M with 16.07% growth.

• Revenue (ttm): $610.66M
• Revenue Growth: +15.27%
• P/S Ratio: 3.03
• Revenue / Employee: $290,792
• Employees: 2,100
• Market Cap: 1.85B USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	591.64M	81.92M	16.07%
Dec 31, 2022	509.73M	25.40M	5.24%
Dec 31, 2021	484.33M	39.88M	8.97%
Dec 31, 2020	444.45M	35.62M	8.71%
Dec 31, 2019	408.83M	132.09M	47.73%
Dec 31, 2018	276.74M	36.49M	15.19%
Dec 31, 2017	240.25M	8.44M	3.64%
Dec 31, 2016	231.81M	132.01M	132.27%
Dec 31, 2015	99.80M	12.73M	14.62%
Dec 31, 2014	87.07M	20.60M	31.00%
Dec 31, 2013	66.47M	6.60M	11.02%
Dec 31, 2012	59.87M	16.38M	37.68%
Dec 31, 2011	43.48M	9.11M	26.51%
Dec 31, 2010	34.37M	4.90M	16.63%
Dec 31, 2009	29.47M	9.45M	47.23%
Dec 31, 2008	20.02M	8.51M	73.97%
Dec 31, 2007	11.50M	5.03M	77.65%
Dec 31, 2006	6.48M	4.59M	243.50%
Dec 31, 2005	1.89M	1.33M	237.83%
Dec 31, 2004	558.07K	188.10K	50.84%
Dec 31, 2003	369.97K	276.48K	295.73%
Dec 31, 2002	93.49K	92.49K	9,249.10%
Dec 31, 2001	1,000.00	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.